Reason for request
Inclusion
Clinical Benefit
Clinical Added Value
| minor |
APROKAM 50 mg, powder for solution for injection, provides a minor improvement in actual benefit (IAB IV) compared with standard management of postoperative endophthalmitis associated with cataract surgery.
|
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
h0ZLBy3ZtsgL9pM8